Senior Director, CCIA Portfolio Strategy & Business Development (REMOTE - USA) at Danaher Corporation

Chaska, Minnesota, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Diagnostics, HealthcareIndustries

Requirements

Strategic leadership experience
Portfolio strategy development experience
Business development experience
Strong collaboration skills
Ability to work in a dynamic, fast-paced environment
Patient-care and customer-oriented mindset

Responsibilities

Develop and execute clinical chemistry and immunoassay portfolio strategy
Drive inorganic innovation through business development activities (M&A, licensing, partnerships)
Partner with Danaher, Platform, and OpCo functions to access technology assets
Collaborate with internal R&D, Program, and Product Management teams
Transition OI (Operational Innovation) into NPD (New Product Development) processes
Influence executive-level decisions within the operating company and diagnostics platform
Lead the Strategic Innovation Review process

Skills

Key technologies and capabilities for this role

Portfolio StrategyBusiness DevelopmentM&ALicensingPartnershipsStrategic InnovationR&D CollaborationNew Product DevelopmentExecutive LeadershipClinical ChemistryImmunoassay

Questions & Answers

Common questions about this position

Is this position remote or onsite?

The role is onsite with a preference for Chaska, Minnesota, but remote work is considered.

What is the salary for this Senior Director position?

This information is not specified in the job description.

What key skills and experience are required for this role?

Required experience includes strategic leadership, portfolio strategy development, business development, strong collaboration skills, ability to work in a dynamic fast-paced environment, and a patient-care customer-oriented mindset.

What is the team structure for this position?

The role is part of the Clinical Chemistry & Immunoassay Product and Program Management leadership team and reports to the Vice President, Clinical Chemistry & Immunoassay Innovation, Product & Program Management.

What makes a strong candidate for this Senior Director role?

Strong candidates will have strategic leadership experience in portfolio strategy development and business development, particularly in driving inorganic innovation through M&A, licensing, and partnerships, along with excellent collaboration skills and executive influence.

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters

1969Year Founded

IPOCompany Stage

Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries

10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.

Potential regulatory challenges in the EU for water quality sector.

Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.

The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.

Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.

Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.

Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI

Try Jobo Free